95
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris

, &
Pages 257-266 | Received 19 Apr 2007, Accepted 05 Feb 2008, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mona H Aburahma & Shaimaa M Badr-Eldin. (2014) Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opinion on Drug Delivery 11:12, pages 1865-1883.
Read now

Articles from other publishers (11)

Filiz Bakar-Ates & Ceyda Tuba Sengel-Turk. (2022) Lonidamine loaded Poly(ethylene glycol)–block–poly(ε-caprolacton) nanocarriers inhibited the proliferation of colorectal cancer cells through G0/G1 cell cycle arrest. Journal of Drug Delivery Science and Technology 77, pages 103853.
Crossref
Kenan Can Tok, Mehmet Gumustas, Ceyda Tuba Sengel-Turk, Gulin Amasya, Bilge Bayram & Ebru Arioglu-Inan. (2022) Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples. Journal of Pharmaceutical and Biomedical Analysis 219, pages 114966.
Crossref
Ceyda Tuba Sengel-Turk, Erva Ozkan & Filiz Bakar-Ates. (2022) Box-Behnken design optimization and in vitro cell based evaluation of piroxicam loaded core-shell type hybrid nanocarriers for prostate cancer. Journal of Pharmaceutical and Biomedical Analysis 216, pages 114799.
Crossref
Tirnja RahangdaleNaveen GuptaNeeraj SharmaAnkita Shukla. (2022) In vitro Evaluation of Floating Microspheres of Gabapentin by Solvent Evaporation Method. Research Journal of Pharmaceutical Dosage Forms and Technology, pages 145-149.
Crossref
Ceyda Tuba Sengel-Turk, Mehmet Eray Alcigir, Okan Ekim, Filiz Bakar-Ates & Canan Hascicek. (2020) Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid–polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model. European Journal of Pharmaceutics and Biopharmaceutics 157, pages 211-220.
Crossref
Mehmet Gumustas, Ceyda Tuba Sengel-Turk, Canan Hascicek & Sibel A. Ozkan. (2014) Optimization of a validated stability-indicating RP-LC method for the determination of fulvestrant from polymeric based nanoparticle systems, drugs and biological samples. Biomedical Chromatography 28:10, pages 1409-1417.
Crossref
Ceyda Tuba Sengel Turk, Umut Can Oz, Tugrul Mert Serim & Canan Hascicek. (2013) Formulation and Optimization of Nonionic Surfactants Emulsified Nimesulide-Loaded PLGA-Based Nanoparticles by Design of Experiments. AAPS PharmSciTech 15:1, pages 161-176.
Crossref
C. Tuba Sengel-Turk, Canan Hascicek & Nursin Gonul. (2011) Ethylcellulose-Based Matrix-Type Microspheres: Influence of Plasticizer RATIO as Pore-Forming Agent. AAPS PharmSciTech 12:4, pages 1127-1135.
Crossref
C.T. Şengel, C. Hasçiçek & N. Gönül. (2011) Design of Vitamin E d-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Emulsified Poly (D,L–Lactide–co-Glycolide) Nanoparticles: Influence of Duration of Ultrasonication Energy. Journal of Young Pharmacists 3:3, pages 171-175.
Crossref
C. T. Türk, C. Hasçiçek & N. Gönül. (2009) Evaluation of drug-polymer interaction in polymeric microspheres containing diltiazem hydrochloride. Journal of Thermal Analysis and Calorimetry 95:3, pages 865-869.
Crossref
Filiz Bakar & Ceyda Tuba Sengel Turk. (2022) Lonidamine Loaded Poly(Ethylene Glycol)–Block–Poly(ε-Caprolacton) Nanocarriers Inhibited the Proliferation of Colorectal Cancer Cells Through G0/G1 Cell Cycle Arrest. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.